Clinical Trials Browser

Phase 2/3 × Glioblastoma × Irinotecan × Clear all

NCT01308632 2011-03-04

Metronomic Temozolamide in Patients With Recurrent Glioblastoma

Phase 2/3 Unknown

Glioblastoma